Clinical Trials Directory

Trials / Completed

CompletedNCT00542282

Vibration Response Imaging in Chronic Obstructive Pulmonary Disease and Asthma

Evaluation of Vibration Response Imaging (VRI) in Chronic Obstructive Pulmonary Disease and Asthma Patients Before and After Bronchodilators

Status
Completed
Phase
Study type
Observational
Enrollment
75 (estimated)
Sponsor
Deep Breeze · Industry
Sex
All
Age
18 Years – 85 Years
Healthy volunteers
Not accepted

Summary

Obstructive lung disease is usually a differential diagnostic consideration when a patient presents with breathlessness or cough. Spirometry is the key diagnostic test used to confirm airflow obstruction particularly in the primary care setting. Airflow obstruction that completely resolves after administration of a bronchodilator, by definition, excludes a diagnosis of COPD. Evaluation of obstructive lung disease must include pulmonary function testing; bronchoreversibility testing is an adjunct in differentiating between asthma and COPD. Bronchoreversibility cannot serve as an absolute diagnostic criterion for separating asthma from COPD. Vibration response imaging (VRI) technology provides a simple, radiation-free method to image the lungs, by visualizing vibration energy (lung sounds) emitted during respiration cycle. In this study, regional quantitative and qualitative information on vibration response is compared with spirometry in assessing lungs function of COPD and Asthma patients.

Conditions

Timeline

Start date
2006-11-01
Completion
2007-08-01
First posted
2007-10-11
Last updated
2009-06-16

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00542282. Inclusion in this directory is not an endorsement.

Vibration Response Imaging in Chronic Obstructive Pulmonary Disease and Asthma (NCT00542282) · Clinical Trials Directory